709 related articles for article (PubMed ID: 29404570)
1. Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease.
Bansal N; Szpiro A; Reynolds K; Smith DH; Magid DJ; Gurwitz JH; Masoudi F; Greenlee RT; Tabada GH; Sung SH; Dighe A; Go AS
JAMA Intern Med; 2018 Mar; 178(3):390-398. PubMed ID: 29404570
[TBL] [Abstract][Full Text] [Related]
2. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
[TBL] [Abstract][Full Text] [Related]
3. Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators.
Bansal N; Szpiro A; Masoudi F; Greenlee RT; Smith DH; Magid DJ; Gurwitz JH; Reynolds K; Tabada GH; Sung SH; Dighe A; Cassidy-Bushrow A; Garcia-Montilla R; Hammill S; Hayes J; Kadish A; Sharma P; Varosy P; Vidaillet H; Go AS
Heart; 2017 Apr; 103(7):529-537. PubMed ID: 27742796
[TBL] [Abstract][Full Text] [Related]
4. Estimated Glomerular Filtration Rate and Implantable Cardioverter-Defibrillator in Nonischemic Systolic Heart Failure: Extended Follow-Up of DANISH.
Doi SN; Thune JJ; Nielsen JC; Haarbo J; Videbæk L; Yafasova A; Bruun NE; Gustafsson F; Eiskjær H; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Køber L; Butt JH
J Am Heart Assoc; 2024 Feb; 13(3):e031977. PubMed ID: 38293926
[TBL] [Abstract][Full Text] [Related]
5. Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease.
Hess PL; Hellkamp AS; Peterson ED; Sanders GD; Al-Khalidi HR; Curtis LH; Hammill BG; Pun PH; Curtis JP; Anstrom KJ; Hammill SC; Al-Khatib SM
Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):793-9. PubMed ID: 25038119
[TBL] [Abstract][Full Text] [Related]
6. Implantable cardioverter defibrillators in chronic kidney disease.
Mc Causland FR; Pfeffer MA
Nat Rev Nephrol; 2018 Jun; 14(6):357-358. PubMed ID: 29651098
[No Abstract] [Full Text] [Related]
7. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials.
Pun PH; Al-Khatib SM; Han JY; Edwards R; Bardy GH; Bigger JT; Buxton AE; Moss AJ; Lee KL; Steinman R; Dorian P; Hallstrom A; Cappato R; Kadish AH; Kudenchuk PJ; Mark DB; Hess PL; Inoue LY; Sanders GD
Am J Kidney Dis; 2014 Jul; 64(1):32-9. PubMed ID: 24518128
[TBL] [Abstract][Full Text] [Related]
8. Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
Kusumoto FM; Bailey KR; Chaouki AS; Deshmukh AJ; Gautam S; Kim RJ; Kramer DB; Lambrakos LK; Nasser NH; Sorajja D
J Am Coll Cardiol; 2018 Oct; 72(14):1653-1676. PubMed ID: 29097297
[TBL] [Abstract][Full Text] [Related]
9. Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies.
Makki N; Swaminathan PD; Hanmer J; Olshansky B
Europace; 2014 Jan; 16(1):55-62. PubMed ID: 24058182
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
[TBL] [Abstract][Full Text] [Related]
11. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
[TBL] [Abstract][Full Text] [Related]
12. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
[TBL] [Abstract][Full Text] [Related]
13. Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure.
Fudim M; Ali-Ahmed F; Parzynski CS; Ambrosy AP; Friedman DJ; Pokorney SD; Curtis JP; Fonarow GC; Masoudi FA; Hernandez AF; Al-Khatib SM
JAMA Cardiol; 2020 Jun; 5(6):643-651. PubMed ID: 32211811
[TBL] [Abstract][Full Text] [Related]
14. Implantable Cardioverter-Defibrillator Placement for Primary Prevention in 2,346 Patients: Predictors of One-Year Survival.
Merchant FM; Desai Y; Addish MA; Kelly K; Casey M; Goyal A; Leon AR; El-Chami MF
Tex Heart Inst J; 2018 Aug; 45(4):221-225. PubMed ID: 30374229
[TBL] [Abstract][Full Text] [Related]
15. Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.
Bilchick KC; Wang Y; Cheng A; Curtis JP; Dharmarajan K; Stukenborg GJ; Shadman R; Anand I; Lund LH; Dahlström U; Sartipy U; Maggioni A; Swedberg K; O'Conner C; Levy WC
J Am Coll Cardiol; 2017 May; 69(21):2606-2618. PubMed ID: 28545633
[TBL] [Abstract][Full Text] [Related]
16. Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure.
Chen CY; Stevenson LW; Stewart GC; Bhatt DL; Desai M; Seeger JD; Williams L; Jalbert JJ; Setoguchi S
BMJ; 2015 Jul; 351():h3529. PubMed ID: 26174233
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.
Fröhlich GM; Holzmeister J; Hübler M; Hübler S; Wolfrum M; Enseleit F; Seifert B; Hürlimann D; Lehmkuhl HB; Noll G; Steffel J; Falk V; Lüscher TF; Hetzer R; Ruschitzka F
Heart; 2013 Aug; 99(16):1158-65. PubMed ID: 23813845
[TBL] [Abstract][Full Text] [Related]
18. Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter-Defibrillator Generator Changes.
Bilchick KC; Wang Y; Curtis JP; Shadman R; Dardas TF; Anand I; Lund LH; Dahlström U; Sartipy U; Levy WC
J Am Heart Assoc; 2022 Jul; 11(13):e023743. PubMed ID: 35766293
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes in Patients with Severe Renal Dysfunction Including Dialysis Following Defibrillator Implantation.
Bogdan S; Nof E; Eisen A; Sela R; Rosenheck S; Freedberg N; Geist M; Ben-Zvi S; Haim M; Glikson M; Goldenberg I; Suleiman M;
Am J Nephrol; 2015; 42(4):295-304. PubMed ID: 26529418
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
